Marie Decraecker
7PUBLICATIONS
2CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Jan 03, 2022
Long-term prognosis of patients with metabolic (dysfunction)-associated fatty liver disease by non-invasive methods.Marie Decraecker, Dan Dutartre, Jean-Baptiste Hiriart
|Dec 24, 2021
Is There Still a Place for Tyrosine Kinase Inhibitors for the Treatment of Hepatocellular Carcinoma at the Time of Immunotherapies? A Focus on Lenvatinib.Marie Decraecker, Caroline Toulouse, Jean-Frédéric Blanc
|Oct 22, 2021
Long-term prognosis of patients with alcohol-related liver disease or non-alcoholic fatty liver disease according to metabolic syndrome or alcohol use.Marie Decraecker, Dan Dutartre, Jean-Baptiste Hiriart
|Jul 02, 2020
Profile of Cabozantinib for the Treatment of Hepatocellular Carcinoma: Patient Selection and Special Considerations.Audrey Debaillon Vesque, Marie Decraecker, Jean-Frédéric Blanc
Pageof 2